Perceptive Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,330,240
Closed -$8.42M 163
2016
Q4
$8.42M Buy
+1,330,240
New +$8.42M 0.6% 41
2015
Q4
Sell
-123,745
Closed -$1.41M 154
2015
Q3
$1.41M Sell
123,745
-346,255
-74% -$3.95M 0.11% 77
2015
Q2
$7.02M Buy
+470,000
New +$7.02M 0.42% 46
2014
Q1
Sell
-197,500
Closed -$1.5M 120
2013
Q4
$1.5M Buy
197,500
+6,912
+4% +$52.5K 0.18% 54
2013
Q3
$1.39M Buy
+190,588
New +$1.39M 0.11% 55